ITGAV and melanoma: For example, miR-146a exerts a paradoxical role in melanoma tumor cells: this miRNA inhibits tumor metastatic behaviors through ITGAV inhibition, while it concurrently favors tumor growth by activating the AKT/PTEN pathway [82].